New Zealand markets closed


NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
215.80+0.64 (+0.30%)
As of 02:42PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close215.16
Bid215.20 x 800
Ask215.67 x 1000
Day's range212.60 - 217.50
52-week range170.36 - 248.30
Avg. volume456,027
Market cap21.585B
Beta (5Y monthly)0.63
PE ratio (TTM)78.47
EPS (TTM)2.75
Earnings date08 Feb 2022
Forward dividend & yield1.72 (0.80%)
Ex-dividend date22 Nov 2021
1y target est258.00
  • GlobeNewswire

    STERIS to Host a Conference Call for Fiscal 2022 Third Quarter Financial Results on February 9, 2022

    DUBLIN, IRELAND, Jan. 25, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2022 third quarter financial results at 10:00 a.m. ET on February 9, 2022. The conference call can be heard live at or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing third quarter

  • Zacks

    Steris (STE) Earnings Expected to Grow: Should You Buy?

    Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Zacks

    STERIS (STE) to Report Q3 Earnings: What's in the Cards?

    The ongoing integration of Cantel Medical business and robust demand from medical device customers are expected to have contributed to STERIS' (STE) Q3 performance.